According to Biohaven Pharmaceutical 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$3.39 Billion, an increase over its 2022 earnings that were of -HK$4.42 Billion. The earnings displayed on this page is the company's Pretax Income.